Search Within

Bone Marrow Transplant

Formats
  1. Meeting Abstract (1531)
  2. Journal Article (1197)
  3. Review (75)
  4. Research Letter (49)
  5. Book Section (34)
  6. Guidelines (26)
  7. Editorial (24)
  8. Correspondence (18)
  9. Conference Paper (14)
  10. Book Whole (1)
  11. Miscellaneous (1)
Groups
  1. Center for Hematologic Malignancies (2970)
  2. Department of Medicine (2970)
  3. Hematologic Malignancies, Division of (2847)
  4. Survivorship Research (1388)
  5. GSK Faculty (931)
  6. CTCR Scholars (873)

More Groups

People
  1. Sergio Giralt (1068)
  2. Miguel-Angel Perales (943)
  3. Sean Devlin (470)
  4. Ann Jakubowski (459)
  5. Gunjan Shah (446)
  6. Heather Landau (435)

More People

Years
  1. 2025 (67)
  2. 2024 (212)
  3. 2023 (263)
  4. 2022 (201)
  5. 2021 (177)
  6. 2020 (208)

More Years

Publications
  1. Blood (887)
  2. Biology of Blood and Marrow Transplantation (516)
  3. Bone Marrow Transplantation (175)
  4. Journal of Clinical Oncology (127)
  5. Transplantation and Cellular Therapy (113)
  6. Blood Advances (94)

More Publications

Publishers
  1. American Society of Hematology (988)
  2. Elsevier Inc. (767)
  3. Nature Publishing Group (261)
  4. American Society of Clinical Oncology (130)
  5. Wiley Blackwell (66)
  6. Taylor & Francis Group (65)

More Publishers

Results (2970)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second complete remission: A comparison with allografts from adult unrelated donors
    Journal Article

    Marks, D. I.; Woo, K. A.; Zhong, X.; Appelbaum, F. R.; Bachanova, V.; Barker, J. N.; Brunstein, C. G.; Gibson, J.; Kebriaei, P.; Lazarus, H. M.; more...
    Haematologica (2014)

    Fulltext@MSK | Save
  • Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy
    Journal Article

    Eapen, M.; Klein, J. P.; Ruggeri, A.; Spellman, S.; Lee, S. J.; Anasetti, C.; Arcese, W.; Barker, J. N.; Lee, A. B. L.; Brown, M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Proceedings from the National Cancer Institute's second international workshop on the biology, prevention, and treatment of relapse after hematopoietic stem cell tansplantation: Part III. Prevention and treatment of relapse after allogeneic transplantation
    Journal Article

    de Lima, M.; Porter, D. L.; Battiwalla, M.; Bishop, M. R.; Giralt, S. A.; Hardy, N. M.; Kröger, N.; Wayne, A. S.; Schmid, C.
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Multiparameter flow cytometry for detection of minimal residual disease in multiple myeloma after T-cell depleted allogeneic stem cell transplant
    Meeting Abstract

    Kosuri, S.; Smith, K. M.; Kuk, D.; Devlin, S. M.; Maslak, P. G.; Giralt, S.; Koehne, G.
    Blood (2013)

    Fulltext@MSK | Save
  • Intensified mycophenolate mofetil (MMF) dosing every 8 hours is safe from the standpoint of engraftment and may ameliorate severe acute graft-versus-host disease (GVHD) after double-unit cord blood transplantation (CBT)
    Meeting Abstract

    Ponce, D. M.; Harnicar, S. J.; Devlin, S.; Hilden, P.; Evans, K. L.; Lubin, M. N.; Giralt, S. A.; Goldberg, J. D.; Perales, M. A.; Kernan, N. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Myeloproliferative Neoplasm Quality of Life (MPN-QOL) Study Group: Observational study of quality of life and symptomatic response in myelofibrosis patients receiving undergoing treatment with conventional therapy, the measures trial and allogeneic stem cell transplant, the symptoms trial
    Meeting Abstract

    Fauble, V.; Emanuel, R. M.; Geyer, H. L.; Dueck, A. C.; Kroeger, N.; Scott, B. L.; Gerds, A. T.; Popat, U. R.; Giralt, S. A.; Gupta, V.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic cell transplantation is effective in patients with advanced systemic mastocytosis: A multicenter retrospective analysis
    Meeting Abstract

    Ustun, C.; Reiter, A.; Scott, B. L.; Nakamura, R.; Gandhi, D.; Kreil, S.; Shanley, R.; Hogan, W. J.; Perales, M. A.; Shore, T. B.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Influence of killer immunoglobulin-like receptor (KIR) and HLA genotypes on outcomes after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation for patients with AML and MDS: A report from the Center For International Blood and Marrow Transplant Research Immunobiology Working Committee
    Meeting Abstract

    Sobecks, R. M.; Gallagher, M. M.; Askar, M.; Haagenson, M. D.; Wang, T.; Spellman, S.; Lee, S. J.; Fernandez Viña, M. A.; Muller, C. R.; Verneris, M. R.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Adverse cytogenetic abnormalities at diagnosis are the most important predictor of relapse post T cell depleted (TCD) allogeneic hematopoietic stem cell transplantation in patients with advanced myelodysplastic syndrome (MDS)
    Meeting Abstract

    Tamari, R.; Jakubowski, A. A.; Papadopoulos, E. B.; Giralt, S. A.; Goldberg, J. D.; Ponce, D. M.; Sauter, C. S.; Hilden, P.; Devlin, S.; Young, J. W.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Low CD34 cell dose is associated with higher non-relapse and overall mortality after reduced intensity conditioning hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndrome
    Meeting Abstract

    Thörlén, J.; Ringdén, O.; Le Rademacher, J.; Battiwalla, M.; Chen, J.; Ho, V. T.; Kebriaei, P.; Keever-Taylor, C. A.; Kindwall-Keller, T. L.; Lazarus, H. M.; more...
    Blood (2013)

    Fulltext@MSK | Save